1. Home
  2. MEHA vs OGEN Comparison

MEHA vs OGEN Comparison

Compare MEHA & OGEN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

MEHA

Functional Brands Inc.

N/A

Current Price

$0.19

Market Cap

3.3M

Sector

Health Care

ML Signal

N/A

Logo Oragenics Inc.

OGEN

Oragenics Inc.

HOLD

Current Price

$0.74

Market Cap

3.6M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
MEHA
OGEN
Founded
2020
1996
Country
United States
United States
Employees
N/A
N/A
Industry
Medicinal Chemicals and Botanical Products
Biotechnology: Pharmaceutical Preparations
Sector
Health Care
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
3.3M
3.6M
IPO Year
N/A
N/A

Fundamental Metrics

Financial Performance
Metric
MEHA
OGEN
Price
$0.19
$0.74
Analyst Decision
Analyst Count
0
0
Target Price
N/A
N/A
AVG Volume (30 Days)
852.3K
911.2K
Earning Date
05-29-2026
03-13-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$6,797,059.00
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
5.57
N/A
52 Week Low
$0.18
$0.74
52 Week High
$8.00
$18.90

Technical Indicators

Market Signals
Indicator
MEHA
OGEN
Relative Strength Index (RSI) 34.16 35.71
Support Level $0.18 $0.77
Resistance Level $0.22 $0.84
Average True Range (ATR) 0.02 0.07
MACD 0.00 -0.01
Stochastic Oscillator 14.04 4.00

Price Performance

Historical Comparison
MEHA
OGEN

About MEHA Functional Brands Inc.

Functional Brands Inc operates in the nutraceutical supplement industry. It is a manufacturer and distributor of supplements in categories such as pain, energy, prenatal, general health, bone and joint, gastro, immunity, cardiac, detox, brain and memory, sleep, prenatal and urinary. It is focus on end-consumers through different channels that include pharmacies, wholesalers, international distributors and direct-to-consumers sales. The Company has two reportable segments: 1) Kirkman, which sells a range of nutraceuticals, supplements and related products direct to consumers; 2) HT Naturals, which sells a range of hemp products; and 3) Corporate, which generates no revenue. Key revenue is generated from Kirkman.

About OGEN Oragenics Inc.

Oragenics Inc is engaged in the research and development of nasal delivery pharmaceutical medications in neurology and fighting infectious diseases. The company's product ONP-002 is a fully synthetic, non-naturally occurring neurosteroid, is lipophilic, and can cross the blood-brain barrier to rapidly reduce swelling, oxidative stress and inflammation while restoring proper blood flow through gene amplification. The Company operates in one reportable segment, which includes activities related to advancing the development of its concussion drug, ONP-002.

Share on Social Networks: